Equivalencies: 0 | Classes: 0 | Children: 0 | Explore

Appears in Networks 5

In-Edges 4

p(HGNC:HTT, var("?")) increases act(p(FPLX:Caspase)) View Subject | View Object

A study in cultured mouse neuroblastoma cells showed that N-terminal mutant Huntingtin inhibited the 20S proteasome catalytic activity, in turn causing impaired proteasomal degradation of p53, subsequent loss of mitochondrial membrane potential, release of cytochrome c, caspase activation, and apoptosis (Jana et al., 2001) (Figure 2). PubMed:14556719

p(HGNC:STUB1) negativeCorrelation act(p(FPLX:Caspase)) View Subject | View Object

Recent data suggest that caspases are involved in the accumulation of tau pathology [10, 25, 26], and reductions in CHIP have been shown to cause caspase activation and increased caspase-cleaved tau levels [19]. PubMed:25374103

p(HGNC:STUB1) increases deg(p(FPLX:Caspase)) View Subject | View Object

These results indicate that CHIP is involved in degradation of caspases and caspase-cleaved tau. PubMed:25374103

path(MESH:Tauopathies) positiveCorrelation p(FPLX:Caspase) View Subject | View Object

Recent data suggest that caspases are involved in the accumulation of tau pathology [10, 25, 26], and reductions in CHIP have been shown to cause caspase activation and increased caspase-cleaved tau levels [19]. PubMed:25374103

Out-Edges 5

p(FPLX:Caspase) increases deg(p(HGNC:MAPT)) View Subject | View Object

Human brain tau can be degraded by the proteases, such as cathepsin-D, amino peptidases, human high temperature requirement serine protease A1 (HTRA1), thrombin, caspases, and calpains (Chesser et al. 2013; Kenessey et al. 1997) PubMed:29626319

p(FPLX:Caspase) increases deg(p(HGNC:MAPT)) View Subject | View Object

It has been reported that tau is degraded by several major cellular degradation systems, including calpain, caspases, lysosomes, and proteasomes. PubMed:22908190

p(FPLX:Caspase) positiveCorrelation path(MESH:Tauopathies) View Subject | View Object

Recent data suggest that caspases are involved in the accumulation of tau pathology [10, 25, 26], and reductions in CHIP have been shown to cause caspase activation and increased caspase-cleaved tau levels [19]. PubMed:25374103

act(p(FPLX:Caspase)) negativeCorrelation p(HGNC:STUB1) View Subject | View Object

Recent data suggest that caspases are involved in the accumulation of tau pathology [10, 25, 26], and reductions in CHIP have been shown to cause caspase activation and increased caspase-cleaved tau levels [19]. PubMed:25374103

p(FPLX:Caspase) increases p(HGNC:MAPT, frag("26_230")) View Subject | View Object

This fragment was proposed to be generated by caspases (although not caspase 3). PubMed:26631930

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.